Immunomodulating Agents
Home > API Products > Immunomodulating Agents
Tofacitinib Citrate
- Category Rheumatoid Arthritis,Psoriatic Arthritis
- CAS 540737-29-9
- Specification In-house
- US DMF 37532
- CEP / Other DMF N/A
- GMP certification TFDA
- Inspection TFDA
- StatusCommercial
- Major Market USA, EU and Japan Market
Tofacitinib Citrate is indicated for Rheumatoide Arthritis,Psoriatic Arthritis, Ulcerative Colitis, Juvenile Idiopathic Arthritis.